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ABSTRACT The effect of glucocorticoids on collagen synthesis was examined in cultured
bovine aortic smooth muscle (BASM) cells . BASM cells treated with 0.1 p,M dexamethasone
during their proliferative phase (11 d) were labeled with [3H]proline for 24 h, and the acid-
precipitable material was incubated with bacterial collagenase. Dexamethasone produced an
approximate twofold increase in the incorporation of proline into collagenase-digestible
protein (CDP) and noncollagen protein (NCP) in the cell layer and medium . The stimulation
was present in both primary mass cultures and cloned BASM. An increase in CDP and NCP
was detected at 0.1 nM, while maximal stimulation occurred at 0.1 /,M. Only cells exposed to
dexamethasone during their log phase of growth (1-6 d after plating) showed the increase in
CDP and NCP when labeled 11 d after plating. The stimulatory effect was observed in BASM
cells treated with the natural bovine glucocorticoid, cortisol, dexamethasone, and testosterone,
but was absent in cells treated with aldosterone, corticosterone, cholesterol, 17 ß-estradiol,
and progesterone. The increase in CDP and NCP was absent in cells treated with the inactive
glucocorticoid, epicortisol, and totally abolished by the antagonist, 17a-hydroxyprogesterone,
suggesting that the response was mediated by specific cytoplasmic glucocorticoid receptors.
Dexamethasone-treated BASM cells showed a 4.5-fold increase in the specific activity of
intracellular proline, which was the result of a twofold increase in the uptake of proline and
depletion of the total proline pool . After normalizing for specific activity, dexamethasone
produced a 2 .4- and 2 .8-fold increase in the rate of collagen and NCP synthesis, respectively.
Cells treated with dexamethasone secreted 1 .7-fold more collagen protein in 24 h compared
to control cultures . The BASM cells secreted 70% Type I and 30% Type III collagen into the
media as assessed by two-dimensional gel electrophoresis. The ratio of these two types was
not altered by dexamethasone. The results of the present study deomonstrate that glucocor-
ticoids can act directly on vascular smooth muscle cells to increase the synthesis and secretion
of collagen and NCP.
Collagen is a major structural protein secreted into the extra-
cellular space where it is involved in several diverse processes,
including platelet aggregation, cell adhesion, differentiation,
and cell proliferation (for a review, see reference 1). In addi-
tion to collagen's role in normal processes, alterations in
collagen metabolism are key components in the pathogenesis
of skin, and vascular diseases and pulmonary fibrosis (2).
Although the underlying mechanisms that regulate collagen
metabolism during normal and pathological states are poorly
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understood, many factors influence the rate and types of
collagen synthesized (3). Prominent among these factors are
several steroid hormones (4, 5), particularly glucocorticoids
thatexert diverse effects on collagen metabolism in connective
tissue cells (for a review, see reference 6).
Most reports have indicated that glucocorticoids inhibit the
rate of collagen synthesis in dermal fibroblasts (7), skin (8),
granulation tissue (9), and hepatocytes (10). While the exact
nature of this inhibition is unknown, collagen synthesis has
541been shown to decline nonselectively (9) as a result of a
generalized anti-anabolic effect which leads to a decrease in
cell growth (11, 12), DNA synthesis (11, 12), and protein
synthesis (8-11). Other investigators, however, have reported
that glucocorticoid treatment selectively decreases collagen
synthesis in rat skin (8) and fibroblasts from normal and
keloid skin (12). More recently, it has been demonstrated that
glucocorticoids produce a specific decrease in collagen mes-
senger RNA in rat lung and skin (13) and chick tendon cells
(14) when measured by an in vitro translation system.
In connective tissue-derived cells glucocorticoids are also
known to inhibit the enzymes prolyl hydroxylase (15-17),
lysyl hydroxylase (16), glucosyltransferase (16), galactosyl-
transferase (16), and lysyl oxidase (17), all of which are
involved in the posttranslational modification and resultant
maturation of collagen. The inhibition of these enzymes by
glucocorticoids may result in a decline in net collagen by
decreasing its stability, leading to enhanced degradation (1).
Regardless of the mechanism of action of glucocorticoids at
each of these loci, it is clear from the above studies that these
steroids may be involved in regulating collagen levels by
altering its synthesis, degradation, or cross-linking. While
studies examining the glucocorticoid regulation of collagen
synthesis in vitro have been limited primarily to connective
tissue cells, the present report has examined their effects on
vascular smooth muscle cells grown in culture.
Numerous laboratories have reported that vascular smooth
muscle cells synthesize and secrete Types I and III collagens
and, to a lesser extent, Type V collagen both in vivo and in
vitro (18-20). Recently, attention has focused on the factors
that influence the quantity and types ofcollagen synthesized
by vascular smooth muscle cells because they are primarily
responsible for elaborating collagen and other extracellular
material that accumulates in the intima during atherosclerosis
(21). In this regard, platelets (22), estradiol (23), insulin, and
diabetic serum (24) have been shown to altercollagen synthe-
sis in smooth muscle cells.
In view of the known effects of glucocorticoids on collagen
metabolism in connective tissue, the increased rate ofcollagen
synthesis and deposition during vascular diseases (25, 26),
and our recent studies that indicate that glucocorticoids in-
hibitsmooth muscle cell proliferation (27, 28), we investigated
the effect ofthese steroids on collagen synthesis by both cloned
and primary mass cultured bovine aortic smooth muscle cells.
Our study demonstrates that glucocorticoid treatment of rap-
idly proliferating aortic smooth muscle cells results in a non-
selective increase in the rate of collagen synthesis and secre-
tion. In contrast, a progressive decrease in collagen synthesis
was observed in cellsexposed to glucocorticoids afterreaching
confluence.
MATERIALS AND METHODS
Dulbecco's modified Eagle's medium (DME),' Dulbecco's phosphate-buffered
saline (PBS), trypsin, penicillin-streptomycin, fungizone, and glutamine were
purchased from Grand Island Biological, Co. (Grand Island, NY). Bovine calf
serum was obtained from Sterile Systems Inc., (Logan, UT). Tissue culture
dishes were obtained from Costar Division, Bellco Glass Inc., (Vineland, NJ).
'Abbreviations used in this paper. DME, Dubecco's modified Eagle's
medium; BASM, bovine aortic smooth muscle; CDP, collagenase-
digestible protein; NCP, noncollagen protein; FGF, fibroblast growth
factor; PBS, phosphate-buffered saline; TCA, trichloroacetic acid;
TEMED, NNN',N'-tetramethylethylenediame; SAS, solubilizer for
aqueous samples; butyl PBD, 2-(4'-t-butylphenyl)-5-4"-biphenyl)-
1,3,4-oxadiazole.
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Acrylamide, his, Coomassie Blue (R-250), TEMED, and ammonium persulfate
were obtained from Bio-Rad Laboratories (Richmond, CA). Specially pure
SDS was obtained from British Drug Houses (Poole, England). Ampholines
were purchased from LKB Instruments (Rockville, MD). L-[5'H]proline (10-
20 Ci/mmol) was obtained from Amersham Corp. (Arlington Heights, IL).
Pepsin was obtained from Worthington Biochemicals (Freehold, NJ). Clostri-
dial collagenase (Form III) was purchased from Advance Biofactures Corp.
(Lynbrook, NY). SAS and butyl PBD were obtained from Research Products
International Corp. (Mount Prospect, IL). Protosol and omnifluor were ob-
tained from New England Nuclear (Boston, MA) and Sodium salicylate from
Mallinckrodt Inc. (Paris, KY). All other chemicals were purchased from Sigma
Chemical Co. (St. Louis, MO).
Cell Culture
Bovine aortic smooth muscle (BASM) cells were isolated from an adult
aortic arch by collagenase/elastasedigestion according to the method ofCham-
ley-Campbell et al. (29). Following establishment of the primary culture, the
cells were cloned in the presence offibroblast growth factor(FGF) as previously
described (27).
Stock BASM cells were maintained and subcultured in DME (H-16) con-
taining 3.7 g/liter NaHC0;, 50 U/ml penicillin, 50 ~sg/ml streptomycin, 2.5
,ag/ml fungizone, and 0.6 mg/ml glutamine. For cloned cells, FGF (250 ng/
ml) was added every other day to the stock cultures until the cells reached
subconfluent densities. The cells were passaged weekly at a seeding density of
5 x 10' cells/60-mm dish and incubated at 37°C in a 5% C02 humidified
incubator. Smooth muscle extracellular matrix-coated dishes were prepared as
described previously (28).
For experiments, stock cells were detached with 0.025% trypsin: 1 mM
EDTA solution, and counted with a hemocytometer. Cells were seeded in 60-
mm tissue culture dishes at a density of 50,000 cells/dish. Steroids were
dissolved in 95% ethanol and added to the medium at a 1:1,000 dilution.
Control cells received anequalvolume ofethanol. 5 d afterplating, themedium
was changed and the steroid was replaced. When the cells reached confluence
(day 10-11), they were washed with 3 ml of DME and preincubated for I h in
2 ml ofDME containing penicillin, streptomycin, fungizone, 50 ,g/ml sodium
ascorbate, and 80 ag/ml ß-aminopropionitrile. The medium was aspirated and
replaced with 2 ml of fresh preincubation medium containing 10-20 uCi/ml
L-5['H]proline and the cells were incubated at 37°C for 24 h. Steroids were
added during both the preincubation and incubation periods. Following incu-
bation, the medium was harvested into plastic tubes containing phenylmeth-
ylsulfonyl fluoride, N-ethylmaleimide, EDTA, to yield final concentrations of
0.2, 10, and 2.5 mM, respectively. The cells were washed twice with PBS, and
the first wash was combined with the appropriate medium. Cellular material
was removed from the medium by centrifugation at 1,000 g for 5 min at 4°C.
The media and tissue culture dishes were stored at -70°C until analysis.
Determination of the Amount of Incorporation of
[3H]Proline into Collagen and Noncollagen
Protein
MEDIUM : Proteins in the medium were precipitated with 10% TCA
containing 1 mM proline in the presence of 100 jug/ml bovine serum albumin.
After chilling on ice for 1 h, the samples were centrifuged at 35,000 g for 30
min at 4°C. Unincorporated ['H]proline was removed by resuspending the
pellet twice in 10% trichloroacetic acid (TCA). The pellet was dissolved in 0.2
N NaOH, and the collagenase-digestable protein (CDP) and noncollagen pro-
tein (NCP) were quantitated as described by Peterkofsky and Diegelmann (30)
using 100 U/ml purified Clostridial collagenase. The collagenase used in the
following experiments was found to be free of proteolytic activity as assayed
with ['H]tryptophan-labeled BASM medium proteins.
CELL LAYER: The cell layer was solubilized in 0.5 N NH40H and
removed from the tissue culture dishes with the aid of a rubber policeman.
TCA was added to the samples to a final concentration of 10%. The samples
were then centrifuged, and the washed pellets were dissolved in 0.2 N NaOH
as described above. An aliquot ofthe NaOH solution was either incubatedwith
collagenase for CDP and NCP determination or added directly to SAS:butyl
PBD toluene cocktail to determine total ['H]profine incorporation. The re-
maining portion was used to quantitate DNA by the method of Burton (31)
using calf thymus DNA as a standard.
Determination of the Intracellular Proline Specific
Activity and Rate of Protein Synthesis
Confluent control and dexamethasone-treated BASM cells were pulsed with
30,uCi/ml ['H]proline for 30 min at 37°C. After aspiration ofthe medium, thecells were rapidly washed four times with 5 ml of ice-cold PBS and the tissue
culture dishes were immediately stored at -70°C. Thecell layerwassolubilized
in 0.5 N NH40H and precipitated with 10% TCA without proline. The acid-
precipitable material was dissolved in 0.2 N NaOH and CDP, NCP, and DNA
was determined. The first TCA-soluble fractions from three dishes were com-
bined to quantitate the specific activity ofthe intracellularproline. To measure
the amount of unincorporated ['H]proline, we counted an aliquot ofthe TCA-
soluble fraction in SAS:butyl PBD toluene. The total intracellular proline
content was determined by the colorimetric method ofTroll and Lindsley (32)
after the TCA was extracted five times with water-saturated ether. The rate of
['H]proline incorporation was normalized by dividing the total incorporation
of['H]proline into CDPandNCP by the specific activity ofthe free intracellular
proline.
Preparation of Collagen Standards
Collagen Types I and III were purified from bovine placenta after digestion
with pepsin for 24 h at 4°C (33). The pepsin-digested material was centrifuged
at 10,000 g for 1 h at 4°C, and crystalline NaCI was added to the supernatant
fraction to a final concentration of0.7 M. The precipitate that developed after
stirring overnight at 4°C was dissolved in 1 M NaCI, 50 mM Tris-HCI, pH 7.8.
Types I and III collagenswerepurified by repeated salt fractionation at 2.6 and
1 .6 M, respectively (34).
Determination of the Types and Specific Activity
of Secreted Collagen
BASM cells were treated with dexamethasone and labeled with 10,uCi/ml
['H]proline for24 h asdescribed above. The media was harvested into protease
inhibitors and dialyzed against 0.5 M acetic acid for 48 h at 4°C. Noncollagen
protein was degraded by the addition of 2.5 ug/ml pepsin directly into the
dialysis tubing. The samples were dialyzed for an additional 18 h, immediately
frozen, and then lyophilized. To determine the specific activity of collagen, we
dissolved the lyophilized samples in sample buffer (35) by boiling for 5 min.
The collagen chains were separated by interrupted SDS PAGE accordingto the
methods of Sykes (36) and Laemmli (35) using a 5% separating gel containing
0.5 M urea. Following SDS PAGE the gels were stained with 0.1 % Coomassie
Brilliant Blue (R-250) in 50% TCA for 15 min. The gels were destained
overnight with 7% acetic acid:5% methanol solution, and the amount of
collagen present was quantitated by measuring the area ofabsorbance of the
Coomassie-Blue-stained bands at 595 nm with a Beckman spectrophometer
(Beckman Instruments, Inc., Palo Alto, CA), equipped with a gel scanner. The
absolute amount of collagen secreted by BASM cells was determined from a
standard curve established using purified Type I collagen. To quantitate the
amount of radioactivity in the a,(I) and a2(I) chains ofType I collagen, we
excised the bands from the gel and solubilized in 10 ml of 3% protosol in
omnifluor-toluene by shaking in a water bath for 18 h at 37°C. To determine
which collagen types were secreted by the cells, we dissolved the lyophilized
media proteins in 50 pl of lysis buffer, and performed nonequilibrium two-
dimensional gel electrophoresisas described by O'Farrell et al. (37), except that
the samples were electrophoresed for 4 h at 400 V in apH 5-7 gradient. For
the second dimension, we used a 5% separating gel containing 0.5 M urea to
fractionate the collagen chains. Under these conditions, the ai(III) chain of
type III collagen could be separated from the aI(I) chain without delayed
reduction and interruption of electrophoresis. For fluorography, the gels were
stainedand destained as described above, incubated for 30 min in I M sodium
salicylate(38), and dried on Whatman 3MM filter paper(Whatman Laboratory
Products, Inc., Clifton, NJ) under vacuum with heating. The dried gels were
exposed in Kodak K-GMAT film at -70°C.
Statistical Analysis
Each datapoint represents the mean ofeitherduplicate ortriplicate samples
± standard error of the mean. In figures where error bars are absent, the
standard error was <I0%.
RESULTS
This study was undertaken to examine the direct effect of
glucocorticoids on collagen synthesis by vascular smooth mus-
cle cells in vitro. In two recent studies (27, 28) we showed
that primary cultures as well as a cloned strain of aortic
smooth muscle cellswere growth inhibited by glucocorticoids.
To determine whether the biochemical response to glucocor-
ticoids in the primary and cloned BASM cellswas also similar,
cells from each culture were treated with 0.1 AM dexametha-
sone throughout their growth phase (11 d) and the incorpo-
ration of ['H]proline into medium CDP and NCP was quan-
titated. As shown in TableI, primary BASM cellstreated with
dexamethasone had a 2.2-fold increase in CDP and a 2.6-fold
increase in NCP. The direction of the response was the same
in the cloned BASM cells, although the magnitude of the
increase was slightly less (1 .7-fold increase in CDP and 2.2-
fold increase in NCP). No major difference in the absolute
amount of incorporation of ['H]proline into CDP and NCP
was observed in the two BASM cultures. However, there was
a greater percentage of collagen present in the medium ofthe
cloned BASM. The results of this experiment demonstrate
that dexamethasone produces a similar increase in the incor-
poration of ['H]proline into CDP and NCP in both the
primary mass cultures and cloned BASM cells. Because of
this observation, we used the cloned BASM cells in future
experiments to further characterize the glucocorticoid effect
since these cells provided the advantage of being a stable cell
strain with an extended lifespan. Although the BASM were
cloned and the stocks maintained in FGF, all cells in the
following studies were grown and analyzed in the absence of
FGF.
Influence of Glucocorticoids on ['H]Proline
Incorporation into Cell Layer and Medium
Protein
As shown in Fig. 1, when BASM cells were treated with
dexamethasone during their proliferative phase (11 d) and
then labeled at confluence with ['H]proline, a large increase
in proline incorporation into acid-precipitable material was
observed in both the cell layer and medium fractions during
the 24-h labeling period. In the cell layer fraction (Fig. l,
upper panel) the glucocorticoid-induced increase was greatest
in the earliest time periods examined (between 0.5 and 2 h).
During this linear period of incorporation the rate of ['H]-
proline incorporation in the dexamethasone-treated cells was
3.0 x 10° dpm/h/Ag DNA compared to 0.7 x 104 dpm/h/,ug
DNA in the control cells. After 6 h, the rate of proline
incorporation began to plateau in both the treated and un-
treated cells and a steady statebetween synthesis,degradation,
and secretion was apparently reached by 8 h, and was main-
tained for at least 24 h.
The data in Fig. l, lower panel, show that ['H]proline
TABLE I
Effect of Dexamethasone on the Incorporation of ['H]Proline
into CDPandNCP
CDP
￿
NCP
￿
% Collagen
(dpm/Ag DNA)
Primary mass culture (second passage) and cloned smooth muscle cells were
treated with 0.1 wM dexamethasone for 11 d. At confluence the cells were
labeled with 10 juCi/ml ['H]proline for 24 h. The incorporation of radioactive
proline into medium CDP and NCP was determined by collagenase digestion
as described in Materials and Methods. The percent collagen was calculated
according to Peterkofsky and Diegelmann (30), using the equation: % colla-
gen = dpm(CDP)/dpm(CDP) + 5.4 dpm(NCP). Each determination represents
the average of triplicate culture dishes ± SE.
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Primary
Control 5,332 ± 130 3,183±67 23 .7+-0.04
DEX (0.1 /AM) 11,979 ± 924 8,355 ± 801 21 .5 ± 0.54
Cloned
Control 8,123 ± 591 2,775 ± 153 35.1 ± 0.04
DEX 14,241 ± 193 6,077 ± 718 30.4 ± 1 .6i 0
g
b
x
ô
Hours
FIGURE 1
￿
Effect of dexamethasone on the rate of incorporation of
['H]proline into acid-precipitable material. Smooth muscle cells
were grown in the absence (O) or presence (4p) of 0.1 ttM dexa-
methasone for 10 d. After the cells were labeled at confluence with
10 pCi/ml ['H]proline for various times, the total incorporation of
proline into cell layer (upper) and medium (lower) protein was
quantitated following precipitation with trichloroacetic acid. Each
point represents the mean of duplicate culture dishes.
containing acid-precipitable material is first detected in the
culture medium -2 h after labeling. During the period of
linear secretion (2-6 h), the dexamethasone-treated cultures
secreted 9.4 x 103 dpm/h/kg DNA while the control cells
secreted 3.0 x 103 dpm/Ag DNA. Thus, during the initial
linear period of labeling, dexamethasone increased ['H]pro-
line incorporation by 4.3-fold in the cell layer and 2.9-fold in
the medium. After 24 h these differences were 2.5-fold and
2.1-fold, respectively. In the following experiments, 24 h was
chosen for a labeling time since the incorporation of proline
into cell layer protein was at a steady state.
Glucocorticoid Dose-Response on Smooth
Muscle Cell Collagen Synthesis
The effect of increasing concentrations of dexamethasone
on the incorporation of ['H]proline into CDP and NCP was
examined by digestion ofacid-precipitable material in the cell
layer and medium with bacterial collagenase. The data shown
in Fig. 2 demonstrate that dexamethasone produced a dose-
dependent increase in the incorporation of ['H]proline into
both CDP and NCP. For both CDP and NCP in the cell layer
and medium, the dose of dexamethasone required to elicit a
half-maximal response was - 1 nM, and a maximal stimula-
tion was observed at a steroid dose of 0.1 AM. At maximal
steroid dose, dexamethasone increased the amount of CDP
by 1 .6-fold and NCP by 2.3-fold in the cell layer. This resulted
in an -50% decrease in the percentage of label appearing in
the CDP fraction (0.85% collagen in control cultures vs.
0.52% collagen in cultures treated with 0.1 AM dexametha-
sone). No major change in percent collagen was observed in
the medium fraction since dexamethasone produced atwofold
increase in CDP and a 2.2-fold increase in NCP. When the
incorporation of ['H]proline into the cell layer and medium
CDP and NCP are considered together, dexamethasone-
treated cultures had a 23% decrease in percent collagen. The
results described above also show that 92% of all collagen
present after 24-h labeling is found in the culture medium.
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FIGURE 2 Effect of increasing concentrations of dexamethasone
on the incorporation of ['H]proline into CDP and NCP. Smooth
muscle cells were exposed to various concentrations of dexameth-
asone for 11 d and then were labeled with 20 ACi/ml ['H]proline
for 24 h. The incorporation of proline into cell layer (A) and medium
(8) CDP (0) and NCP (O) and percent collagen (A) was determined
as described in Materials and Methods. Each determination repre-
sents the mean of duplicate culture dishes.
Because of this observation the following studies examining
the effect ofglucocorticoids on collagen synthesis were limited
to the medium fraction.
Influence of Proliferation Rate or Cell Density on
the Cellular Sensitivity to Glucocorticoid
Treatment
The influence of BASM proliferation rate on the glucocor-
ticoid effect on CDP and NCP production was examined by
exposing cultures to 0.1 AM dexamethasone for various pe-
riods of time during the growth phase. All cells were plated at
50,000 cellsdish, and dexamethasone was added to duplicate
cultures at the time of plating and every other day thereafter
until the cells reached confluence. All cultures were then
labeled with [3H]proline on the eleventh day afterplating. Fig.
3A shows that the twofold increase in ['H]proline incorpora-
tion into secreted CDP and NCP occurred only in BASM
cultures exposed to dexamethasone for 7-11 d before conflu-
ence. In contrast, cells exposed to dexamethasone for 0.5-5 d
before reaching confluence showed a small decrease in CDP
and no change in NCP. Growth rate analysis showed that the
stimulatory effect was present in BASM cells exposed to
dexamethasone only during their log phase of growth. We
also examined the effect of dexamethasone on stationary
BASM cells. In this case, cultures were grown in the absence
of dexamethasone for 11 d and were then exposed to 0.1 AM
dexamethasone for 1, 3, and 5 d after reaching confluence.
Fig. 3B shows that dexamethasone produced a progressive
decrease in the incorporation of [3H]proline into CDP without
affecting proline incorporation into NCP. Thus, these results
clearly demonstrate that the direction of the glucocorticoid
response is dependent upon whether the BASM cells are
proliferating or stationary when exposed to glucocorticoids.
We have shown previously that glucocorticoids inhibit the
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FIGURE 3 Influence of proliferation rate or cell density on the
response of smooth muscle cells to dexamethasone. (A) 0.1 AM
dexamethasone was added to duplicate culture dishes beginning
on the day of plating and every other day thereafter until the cells
reached confluence. All cultures were labeled, on the eleventh day
after plating, with 10,uCi/ml ['H]proline for 24 h . (8) Smooth muscle
cells were grown in the absence of dexamethasone for 11 d. The
cells were then treated with dexamethasone (0.1 AM) for various
times, and all cultures were labeled for 24 h 5 d after reaching
confluence. The medium fraction was analyzed for CDP (0), NCP
(p), and % collagen (A) as described in Materials and Methods.
Each determination represents the mean of duplicate culture dishes.
rate of proliferation and saturation density of this BASM
clone by -40% (27). These observations suggest the possibility
that the increase in proline incorporation may have resulted
from the lower saturation density attained in the glucocorti-
coid-treated cells rather than being a direct effect on protein
synthesis. To examine this question, we took advantage of
our previous observation that BASM extracellular matrix
abolishes the glucocorticoid inhibition of cell proliferation
(28). When BASM cellswere grown on matrix in the presence
of 0.1 AM dexamethasone for 11 d, CDP and NCP were
increased to the same extent as seen in BASM cells grown on
plastic (data not shown). Thus, it is apparent from these
studies that the glucocorticoid stimulatory effect on CDP and
NCP occurs independent of the inhibitory action of this
steroid on BASM proliferation or saturation density.
Steroid Specificity of the Glucocorticoid Effect
The steroid specificity of the glucocorticoid effect on col-
lagen and NCP was examined by treating smooth muscle cell
cultures with various steroids throughout their proliferative
phase (11 d). The data shown in Fig. 4 demonstrate that the
stimulatory effect is glucocorticoid specific and is also mani-
fested by certain natural glucocorticoids as well as dexameth-
asone. No increase in CDP and NCP was observed in BASM
cells treated with corticosterone or the inactive glucocorticoid,
epicortisol (17-a cortisol). Consistent with our previous re-
sults, 0.1 AM dexamethasone produced over a twofold in-
crease in CDP and NCP, while hydrocortisone used at a
concentration of 0.1 AM was as potent as 1 nM dexametha-
sone. The glucocorticoid antagonist, 17 a-hydroxyprogester-
one, decreased CDP and NCP and completely abolished the
178-ESTRADIOL
PRDOESTEnONE
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FIGURE 4
￿
Effect of various steroids on the incorporation of ['H]-
proline into CDP and NCP. All steroids were added to the medium
on the day of plating and every other day thereafter until confluence
to a final concentration of 0.1 AM unless otherwise indicated. All
cultures were labeled on the eleventh day after plating with ['H]-
proline for 24 h, and CDP (striped bar) and NCP (filled bar) was
determined as described in Materials and Methods. Each determi-
nation represents the mean of duplicate culture dishes.
dexamethasone-mediated stimulation of CDP and NCP. A
slight decrease in CDP and NCP was observed in BASM cells
treated with progesterone, while minor increases occurred in
cellstreated with aldosterone, cholesterol, and 17-ß estradiol.
In addition to the glucocorticoids, testosterone was the only
other steroid tested to produce a major increase in CDP and
NCP. In view of the recent report by Horwitz and Korwitz
(39) which identified testosterone receptors in the dog aorta,
it seems likely that this effect is mediated through the andro-
gen receptor system. Finally, none of the steroids tested pro-
duced a major alteration in the percent of collagen present in
the medium.
Influence of Glucocorticoids on the Specific
Activity of the Intracellular Proline Pool and Rate
of Collagen and NCP Synthesis
To further examine the mechanism of the glucocorticoid
stimulation of CDP, we treated smooth muscle cells for 11 d
and then determined the synthetic rate of CDP and NCP
during a 30-min pulse with ['H]proline to minimize any
influence of degradation. To adequately estimate the initial
rate of protein synthesis, we also determined the specific
activity of the intracellular proline pool after this labeling
period.
As shown in Fig. 5A, the dexamethasone-treated BASM
cells had a 2.3-fold increase in the uptake of ['H]proline as
determined by measuring the amount of radioactivity in the
acid-soluble fraction of the cell layer. In addition, the dexa-
methasone-treated cellscontained only one-halfthe quantity
oftotalfree proline inside the cellsas assessed by colorimetric
measurement (Fig. 5 B). These two changes resulted in a 4.5-
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FIGURE 5 Effect of dexamethasone on the intracellular proline
specific activity and rate of collagen and noncollagen protein syn-
thesis. Smooth muscle cells were grown for 11 d in the absence
(empty bar) or presence (striped bar) of 0.1 AM dexamethasone. At
confluence the cells were labeled with 30 ACi/ml ['H]proline for
30 min at 37°C . The uptake of radioactive proline (A), the total
intracellular proline content (B), the intracellular proline specific
activity (C), and the rate of collagen and non-collagen protein
synthesis (D) was measured as described in Materials and Methods.
Each determination represents the mean ± SE from three pooled
culture dishes done in triplicate.
fold increase in the specific activity of the proline pool (Fig.
5 C). When the incorporation of ['H]proline into CDP and
NCP was normalized for the observed differences in the
specific activity ofthe proline pool, dexamethasone produced
an increase in the rate of collagen synthesis by 2.4-fold and
NCP synthesis by 2.8-fold (Fig. 5 D).
Influence of Glucocorticoids on the Specific
Activity of Secreted Collagen
The previous studies have demonstrated that glucocorti-
coids increase the incorporation of ['H]proline into CDP and
NCP as a result of an increased rate of protein synthesis.
However, these experiments did not provide direct evidence
to show that glucocorticoids increase the absolute amount of
collagen secreted by the cells. To address this question, we
determined the specific activity of secreted collagen. In this
case pepsin-digested ['H]proline labeled medium proteins
were separated by interrupted SDS PAGE, and the amount
of collagen present in the gel was determined by measuring
the absorbance ofthe Coomassie-Blue-stained bands. Fig. 6A
shows that there is a linear relationship between the amount
ofpurified Type I collagen standard loaded on the gel and the
area of absorbance of the collagen band. When the media
from control and treated cells were analyzed, it was found
that the control cells secreted 2.7 Ag of the a l(l) chains of
Type I collagen after24 h compared to 4.5 Ag secreted by the
dexamethasone-treated cultures (Fig. 6B). To determine the
amount of radioactivity present in Collagen, the al(l) bands
were excised from the gel and solubilized. Fig. 6 C shows that
the al(l) bands from the dexamethasone-treated cells con-
tained twice the radioactivity of the a,(I) band from the
control cells. Using the above data, it was calculated that the
specific activity of the al(l) chains was -20% greater in the
dexamethasone-treated cells (Fig. 6D). Similar results were
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Effect of dexamethasone on the specific activity of se-
creted collagen. Control (empty bar) and dexamethasone-treated
(striped bar) smooth muscle cells were labeled with 10 ;tCi/ml
['H]proline for 24 h. The medium proteins were digested by pepsin,
and the resultant collagen chains were separated by interrupted
SDS PAGE. (A) Standard curve established by measuring the ab-
sorbance of Coomassie Blue of the a,(I), band from purified bovine
Type I collagen. (B) The absolute amount of the al(l) chains secreted
by smooth muscle cells after 24 h . (C) The amount of radioactivity
present in the a,(I) band from smooth muscle cells. (D) The specific
activity of secreted collagen. Each determination represents the
mean + SE of medium samples from triplicate culture dishes.
obtained when the a2(I) chains of Type I collagen were
analyzed for specific activity. These results demonstrate that
dexamethasone increased the specific activity of secreted col-
lagen by 20%, but cannot account for the twofold increase in
the incorporation of ['H]proline into collagen that we have
consistently observed throughout this study. Furthermore,
these data suggest that the glucocorticoid-treated BASM cul-
tures secreted -70% more collagen into the medium after 24
h.
Influence of Glucocorticoids on the Types of
Collagen Secreted by BASM Cells
At the present time, five major tissue-specific and structur-
ally distinct collagen types have been identified in mamma-
lians (1). Although the role of each type is unknown, changes
in the types of collagen produced in various tissues may be
important in certain pathological conditions (2). Recently, it
has been reported that several hormones, including 17 ß-
estradiol, alter the ratio of collagen types synthesized in cul-
tured vascular smooth muscle cells (23). To investigate
whether glucocorticoids change the proportion of collagen
types secreted, ['H]proline-labeled medium proteins were di-
gested with pepsin, and the resultant collagen a-chains were
separated by two-dimensional gel electrophoresis. As shown
in Fig. 7 the a-chains of Type I and Type III collagens can be
resolved by this technique using a pH 5-7 gradient in the first
dimension. The a-chains present in BASM media from both
the control (Fig. 7A) and the dexamethasone-treated cells
(Fig. 7B) comigrated with the purified a,(111) standard and
the a 1(I) and a2M standards (Fig. 7C) and demonstrate that
these cells secreted Types I and III collagens. Densitometric
scanning of the fluorograms revealed that both the untreated
and dexamethasone-treated cells secreted -70% Type I and
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Û 4FIGURE 7 Effect of dexamethasone on the type of collagen se-
creted by smooth muscle cells . Smooth muscle cells were grown in
the absence (8) or presence (C) of0.1 PM dexamethasone for 11
d . The cells were labeled with 10 pCi/ml ['H]proline for 24 h, and
the medium was harvested and digested with pepsin . The resultant
collagen chains were separated by two-dimensional electrophore-
sis, and the gels were fluorographed . (A) Coomassie-Blue-stained
types I and III collagen standards purified from bovine placenta .
30% Type III collagens. These data indicate that while glu-
cocorticoids increase the rate of collagen synthesis they do
not specifically alter the types of collagen secreted by aortic
smooth muscle cells.
DISCUSSION
Previous studies examining the effects of glucocorticoids on
collagen synthesis have focused almost exclusively on connec-
tive tissue-derived cells. Although several reports have shown
thatglucocorticoids stimulate collagen synthesis (40, 41), most
investigations have found that these steroids exert an inhibi-
tory effect in connective tissue (6). The present study has
demonstrated that glucocorticoids can act directly on vascular
smooth muscle cells to increase the incorporation of proline
into collagen and noncollagen protein . The stimulatory effect
was not selective for collagen and was present in primary
mass cultured as well as cloned cells . The finding that collagen
synthesis is stimulated in smooth muscle cells and inhibited
in connective tissue (6) by glucocorticoids shows that the
direction of the biological response to these hormones is
apparently dictated by the differentiation of the cell .
The increase in proline incorporation occurred with physi-
ological concentrations of glucocorticoids . It was detectable
at 0.1 nM dexamethasone and was maximal at 0.1 uM. These
dose-response characteristics correlate well with the known
binding affinities of the glucocorticoid receptor (42), the glu-
cocorticoid induction of growth hormone (43), tyrosine ami-
notransferase (44), and other specific gene products (46), the
inhibition of BASM proliferation (27), and fibroblast prolif-
eration (11), and the inhibition of collagen synthesis in fibro-
blasts (9).
The stimulation of CDP and NCP was found in BASM
cells treated with the natural bovine glucocorticoid, cortisol,
in addition to the synthetic glucocorticoid, dexamethasone .
No major increase in CDP or NCP was observed in BASM
cells treated with the inactive glucocorticoid, epicortisol, al-
dosterone, cholesterol, estradiol, and progesterone . Further-
more, the stimulatory erect was completely abolished by the
glucocorticoid antagonist, 17 a-hydroxyprogesterone . These
results suggest that the increased proline incorporation is
mediated by specific cytoplasmic glucocorticoid receptors .
More direct support for a receptor-mediated pathway is de-
rived from recent studies that have identified glucocorticoid
receptors in bovine (Lan, N., andL. K. Johnson, unpublished
observations) and rat aortic BASM (46) and the aorta of dogs
(39). In contrast to the report by Beldekas et al . (23) that
showed that 17 l3-estradiol produced a major decrease inCDP
in bovine aortic BASM cells (23), we consistently observed a
minor increase in CDP and NCP with this steroid. We also
observed a major increase in CDP and NCP in BASM cells
treated with testosterone. Although we did not examine vas-
cular BASM cells for testosterone receptors, this effect was
probably mediated by the androgen receptor system since
testosterone receptors have been recently described in dog
aorta (39) .
The stimulation of CDP and NCP was found to be highly
dependent on the time when the cells were exposed to dexa-
methasone. The effect was observed only in cultures treated
with dexamethasone during their log phase of growth (1-6 d
after plating) . In contrast, when subconfluent or confluent
cultures were exposed to dexamethasone, a small decrease in
CDP and no change in NCP occurred . These results suggest
that rapid proliferation is a necessary requirement for the
stimulatory effect . In synchronous cell-lines it has been dem-
onstrated that the cells are sensitive to glucocorticoids only
during specific phases of the cell cycle . For example, the
induction of alkaline phosphatase in HeLa cells (47) and
tyrosine aminotransferase in hepatoma cells (48) is limited to
the S and G, phases, while the glucocorticoid inhibition of
proliferation of the human cell-line NHIK 3025 occurs only
during the G, phase (49) .
Recent studies in this laboratory have shown that glucocor-
ticoids inhibit the proliferation and saturation density ofboth
primary mass cultured and clonedBASM cells (27, 28). It has
been reported that the rate of protein (50) and collagen (51)
synthesis declines with increasing cell density in fibroblasts.
These studies raise the possibility that the increase in CDP
and NCP in the dexamethasone-treated cells was due to the
lower saturation density reached by these cells rather than to
a direct effect on protein synthesis . To address this question,
we labeled cells with ['H]proline during the late log phase of
growth (6 d after plating) instead of at confluence (Leitman,
D., and L . K . Johnson, unpublished observations). In addi-
tion, cells were grown in the presence and absence of dexa-
methasone on tissue culture dishes coated with a homologous
extracellular matrix, which provided conditions whereby dex-
amethasone no longer inhibits the proliferation of this clone
(28) . In both ofthese cases, we observed an increase in CDP
and NCP in the glucocorticoid-treated BASM cells . Thus,
these studies exclude the possibility that the stimulatory effect
resulted from differences in the time or density at which the
treated cells attained confluence . It is also apparent that the
glucocorticoid-induced inhibition ofBASM proliferation can
be dissociated from the increased proline incorporation,
which suggests that the pathway ofglucocorticoid action may
diverge at some point to produce these separate effects .
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treated cells could have resulted from an increase in the rate
ofprotein synthesis,decreased protein degradation, increased
specific activity of intracellular proline, or by a combination
of these processes. The site of glucocorticoid action was in-
vestigated by determining the rate of protein synthesis after
correcting for differences in specific activity of proline. Al-
though the steroid did apparently elevate the intracellular
specific activity of the proline pool, the levels of proline
incorporation when normalized for the proline specific activ-
ity still reflected a twofold increase in the rate ofcollagen and
noncollagen synthesis after glucocorticoid treatment, assum-
ing the extent of protein degradation to be negligible after a
30-min pulse.
If the fourfold increase in the intracellular specific activity
of proline observed after a 30-min pulse was maintained
throughout the labeling period, one would expect that the
level of proline incorporation and protein specific activity
would be elevated to the same extent had dexamethasone not
produced an effect on the rate of protein synthesis. However,
after a 24-h labeling period, we observed only a twofold
increase in proline incorporation into protein and a 20%
increase in the specific activity ofsecreted collagen. A possible
explanation for this apparent disparity is that the specific
activity of the proline pool may vary during the labeling
period as a result of an increased rate of protein degradation
in the steroid-treated cells. This would lead to a drop in the
specific activity of the proline pool over time, due to the
release of unlabeled proline into the cell. It is also possible
that proline is being compartmentalized inside the cells such
that the specific activity of the total intracellular pool may be
significantly different from the proline pool accessible to
prolyl-tRNA (52). Thus, although the total cellular proline
specific activity may be much greater in the treated BASM
cells, the specific activity of the pool that serves as the precur-
sor for prolyl-tRNA may be similar to that in the control
cells.
It is well established that vascular BASM cells synthesize
predominantly Types I and III collagen (20). The exact pro-
portion ofthese two types that are synthesized has been found
to be highly variable, possibly due to differences in the age of
the cells (19) and to the severity ofpepsin treatment (18). We
examined the possible glucocorticoid regulation of the colla-
gen types secreted, since Type I collagen is increased relative
to Type III collagen in atherosclerotic lesions (53) and with
estradiol treatment of BASM cells (23). In the present study
we modified the nonequilibrium two-dimensional gel electro-
phoresis technique of O'Farrell et al. (37) to separate the
collagen chains of Types I and III. Using this method to
separate pepsin-digested medium proteins, we found thatboth
the control and steroid-treated cells secreted -70% Type I
and 30% Type III collagen, a ratio consistent with the findings
of other studies using cultured vascular smooth muscle cells
(54, 55). Thus, although glucocorticoid treatment increases
total collagen production per cell, it does not alterthe relative
types of collagen chains expressed.
The most prominent feature in the pathology ofatheroscle-
rosisis the occurrence ofsmooth muscle cell proliferation and
subsequent elaboration of collagen and other extracellular
material that accumulates in the intima of the arterial wall
(21). It has been reported that the rate ofcollagen synthesis is
increased afterexperimental atherosclerosis in the rabbit aorta
(25) and isolated rabbit atherosclerotic smooth muscle cells
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(56). Furthermore, collagen is the most abundant protein
present in the atherosclerotic lesions, comprising-30% ofthe
total dry weight (57, 58). However, the role of hormones in
the regulation of collagen synthesis and deposition in normal
and atherosclerotic blood vessels is unknown. Organ culture
studies by Manthorpe et al. (59, 60) have demonstrated that
collagen synthesis is decreased in the aorta from prednisone-
treated rabbits. Our finding that glucocorticoids have a minor
inhibitory effect on collagen synthesis in stationary BASM
cells is consistent with their observations, since only a small
number of smooth muscle cells are actively proliferating in
the intact vessel (61). The use of an in vitro system has
provided the opportunity to examine also the effect of gluco-
corticoids on collagen synthesis in proliferating BASM cells.
Our results clearly demonstrate that glucocorticoids have the
capacity to act directly on proliferating smooth muscle cells
to stimulate collagen and noncollagen protein synthesis and
secretion. Although caution must be employed when extrap-
olating the results of an in vitro study to the in vivo situation,
our findings presented here and previously (27, 28) suggest
that, if glucocorticoids have the same effects on proliferating
smooth muscle cells during atherogenesis, they may promote
the development ofa less cellular but more fibrous lesion and
thereby delay the regression of atherosclerotic lesions once
formed.
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